Home » BIOPHAN ACQUIRES EQUITY STAKE IN MYOTECH TO ACCELERATE COMMERCIALIZATION OF BREAKTHROUGH CARDIAC ASSIST DEVICE TECHNOLOGY
BIOPHAN ACQUIRES EQUITY STAKE IN MYOTECH TO ACCELERATE COMMERCIALIZATION OF BREAKTHROUGH CARDIAC ASSIST DEVICE TECHNOLOGY
Biophan Technologies, a developer of next-generation biomedical technology, recently announced it has entered into a purchase agreement to acquire a substantial minority interest in Myotech, the developer of the breakthrough, MYO-VAD cardiac assist device. Biophan has the option to acquire additional equity in Myotech, up to a majority ownership position. The transaction will strengthen Biophan's position in the fast growing multi-billion worldwide market opportunity for cardiac assist devices.
Genetic Engineering News (http://www.genengnews.com/news/bnitem.aspx?name=1118649XSL_NEWSML_TO_NEWSML_WEB.xml)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May